Price Alert: Shares of Enerplus (ERF) Trade 6.63% Higher at Midday May 13

Equities Staff  |

Enerplus Corporation (NYSE: ERF) shares climbed 6.63%, or $0.78 per share, as on 11:54:41 est today. Opening the day at $12.02, 884,498 shares of Enerplus have traded hands and the stock has moved between $12.54 and $12.01.  

So far this year the company has moved YTD 11.43%.

Enerplus anticipates its next earnings on 2022-08-04.

For technical charts, analysis, and more on Enerplus visit the company profile.

About Enerplus Corporation

Enerplus is an independent North American oil and gas exploration and production company focused on creating long-term value for its shareholders through a disciplined, returns-based capital allocation strategy and a commitment to safe, responsible operations.

To get more information on Enerplus Corporation and to follow the company's latest updates, you can visit the company's profile page here: Enerplus Corporation's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content